Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy

Annals of Hematology

Volumn 92, Issue 4, 2013, Pages 497-504

  Cho, Byung Sik ^a   Yahng, Seung Ah ^a   Kim, Jung Ho ^a   Yoon, Jae Ho ^a   Shin, Seung Hwan ^a   Lee, Sung Eun ^a   Choi, Su Mi ^a   Lee, Dong Gun ^a   Eom, Ki Seong ^a   Park, Gyeongsin ^a   Kim, Yoo Jin ^a   Kim, Hee Je ^a   Lee, Seok ^a   Min, Chang Ki ^a   Cho, Seok Goo ^a   Kim, Dong Wook ^a   Lee, Jong Wook ^a   Min, Woo Sung ^a   Park, Chong Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cytomegalovirus gastrointestinal disease; Gastrointestinal graft versus host disease; Preemptive therapy for CMV infection

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; ENDOSCOPIC BIOPSY; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ALLOTRANSPLANTATION; CHEMOPROPHYLAXIS; CYTOMEGALOVIRUS; EVALUATION; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PREMEDICATION; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHEMOPREVENTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREMEDICATION; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877041194     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1632-x     Document Type: Article

References (22)

1. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9:543-558
2. Ljungman P, Hakki M, Boeckh M (2010) Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am 24:319-337
3. Marty FM, Ljungman P, Papanicolaou GA et al (2011) Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis 11:284-292
4. Cheung DY, Kim JI, Kim SS et al (2008) Endoscopic evaluation in gastrointestinal graft-versus-host disease: comparisons with histological findings. Dig Dis Sci 53:2947-2954
5. He JD, Liu YL, Wang ZF, Liu DH, Chen H, Chen YH (2008) Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation. Chin Med J (Engl) 121:1285-1289
6. Washington K, Jagasia M (2009) Pathology of graft-versus-host disease in the gastrointestinal tract. Hum Pathol 40:909-917
7. Kreisel W, Dahlberg M, Bertz H et al (2012) Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant 47:430-438
8. Jang EY, Park SY, Lee EJ et al (2009) Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis 48:e121-124
9. Mori T, Okamoto S, Matsuoka S et al (2000) Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 25:765-769
10. Mori T, Mori S, Kanda Y et al (2004) Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33:431-434
11. Park SY, Lee SO, Choi SH et al (2011) Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes. J Clin Microbiol 49:4179-4184
12. Shulman HM, Kleiner D, Lee SJ et al (2006) Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 12:31-47
13. Przepiorka D, Weisdorf D, Martin P et al (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825-828
14. Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945-956
15. Cho BS, Min CK, Eom KS et al (2008) Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 41:813-820
16. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34:1094-1097
17. Choi SM, Lee DG, Lim J et al (2009) Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp 65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients. J Korean Med Sci 24:571-578
18. Choi SM, Lee DG, Choi JH et al (2005) Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea. Int J Hematol 81:69-74
19. Ljungman P, Reusser P, de la Camara R et al (2004) Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 33:1075-1081
20. Tomblyn M, Chiller T, Einsele H et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15:1143-1238
21. Boeckh M, Ljungman P (2009) How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113:5711-5719
22. Boeckh M (2011) Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program 2011:305-309